Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study
Long-term, open, cohort, multicentre study with the aim of evaluation of response predictors for therapy. The secondary goal also evaluation of glucocorticoids dose change during therapy with abatacept.